FACIT Launches The Prospects Oncology Fund

FACIT Announces Investment in Propellon Therapeutics

From our Annual Report: Investing in the cure and the economy

FACIT Falcons’ Fortunes pitch competition helps Ontario ideas take flight

Privacy Analytics Acquired by IMS Health

OICR partners with Israeli university to create new cancer genomics and immunity program

Trillium Therapeutics Acquires Fluorinov Pharma

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership

FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

Fluorinov Pharma and FACIT Announce Investment in Breakthrough Bromodomain Inhibitors for the Treatment of Cancers